Skip to main content
. 2019 Mar 27;10:571. doi: 10.3389/fimmu.2019.00571

Table 1.

Detail of patients included in the study.

Normoglycemic T2D
Number (n) 30 65
Age (years) 71 ± 0.4 69 ± 0.9
Gender (F%) 13 (43) 46 (35)
Fasting glucose (mg/dL) 101.3 ± 1.2 171.7 ± 5.6*
Hb1Ac (%) N/A 7.37 ± 0.1
BMI (kg/m2) 26.3 ± 0.6 31.4 ± 0.8*
Waist Circumference 91.3 ± 1.5 105.91 ± 1.74*
Total cholesterol (mg/dL) 189.5 ± 4.8 187.27 ± 5.48
HDL-C (mg/dL) 59.7 ± 1.7 48.02 ± 1.85*
LDL-C (mg/dL, Friedewald) 109.7 ± 4.3 109.61 ± 4.70
Triglycerides (mg/dL) 100.1 ± 5.3 148.26 ± 17.4*
C-Reactive Protein (mg/dL) 0.12 ± 0.02 0.58 ± 0.2*
Alanine Aminotransfersae (ALT) (U/L) 19.54 ± 0.96 31.89 ± 4.8*
Aspartate Aminotransferase (AST) (U/L) 24.08 ± 0.61 26.71 ± 3.1*
Gamma Glutamyl Transpeptidase (GGT) (U/L) 28.6 ± 3.15 35.16 ± 2.7*
Fatty Liver Index (%) 37.1 ± 5.7 66.14 ± 3.31*
Creatinine (mg/dL) 0.9 ± 0.04 1.8 ± 0.1*
GFR (mL/min) 71.3 ± 2.34 29.7 ± 1.8*
Urinary albumin (mg/g urinary protein) N/A 202.0 ± 48.1

Number of patients per group, age, gender, fasting glucose, Hb1Ac, BMI, waist circumference serum, cholesterol, HDL, LDL-C, triglyceride, C-reactive protein (CRP), ALT, AST, GGT, FLI, creatinine, GFR, and urinary albumin. Experimental groups: Normoglycemic (n = 30) and patients with type-2 diabetes T2D, (n = 65). Data analyzed by unpaired Student's t-test (normally distributed data) or Mann Whitney U-test (data that are not normally distributed) and expressed as mean ± SEM.

*

p < 0.05; NA, data not available.

HHS Vulnerability Disclosure